Lengthy-term care pharmacies have stopped utilizing the Johnson & Johnson COVID-19 vaccine and are awaiting additional instruction from federal well being officers, who advisable the halt whereas they examine six studies of uncommon and severe blood clots in individuals who obtained it.
Main pharmacies tried to assuage worries after the information broke Tuesday, whereas one pharmacy affiliation official predicted the interruption could possibly be minimal and resolved this week.
A CVS/Omnicare spokesperson stated its long-term care clinics affiliated with the federal program shouldn’t be affected as a result of they don’t use the J&J vaccine.
The subsequent few days will probably be important to figuring out the following plan of action. Federal well being officers will maintain an emergency assembly of the Advisory Committee on Immunization Practices (ACIP) Wednesday to additional assessment these instances and assess potential implications on vaccine coverage.
The Facilities for Illness Management and Prevention and Meals and Drug Administration issued the alert on Tuesday “out of an abundance of warning.” The opposed reactions concerned a sort of blood clot referred to as cerebral venous sinus thrombosis in vaccine recipients ranging in age from 18 to 48.
The response is just identified to have occurred in six ladies among the many 6.8 million doses administered worldwide to date.
The non permanent motion “is vital, partly, to make sure that the healthcare supplier group is conscious of the potential for these opposed occasions and might plan for correct recognition and administration as a result of distinctive therapy required with any such blood clot,” FDA and CDC officers said.
For long-term care, the announcement implies that vaccinations are “primarily halted,” in line with David Gifford, M.D., chief medical officer for the American Well being Care Affiliation.
“Suppliers can work with their native pharmacies to obtain the Pfizer and Moderna vaccines if they can safe it from their state, however we desperately want federal and state public well being officers to allocate extra of those vaccines to our settings. With out swift motion to switch these vaccines, we might see tragic penalties,” an AHCA spokeswoman stated late Tuesday afternoon.
A spokeswoman for CVS Well being and Omnicare advised McKnight’s Lengthy-Time period Care Information late Tuesday that it has applied a pause in the usage of the vaccine. The corporate’s subsequent steps “will probably be decided by suggestions from the CDC and FDA.”
The corporate added that it doesn’t use the Johnson & Johnson vaccine at its long-term care clinics within the federal pharmacy partnership program, that means “at present’s federal steering won’t impression the completion of these efforts.”
T.J. Griffin, chief pharmacy officer for PharMerica, stated the corporate canceled its vaccination clinics using the Johnson & Johnson vaccine that had been scheduled for Tuesday and Wednesday, “pending additional instructors from CDC and FDA.”
“If the advisable pause is prolonged, we’ll transfer shortly to safe doses of the Moderna and/or Pfizer vaccines so as to guarantee our long-term care sufferers have entry,” Griffin stated in a press release to McKnight’s on Tuesday.
The pause is just not anticipated to final lengthy and the general impression could possibly be minimal to long-term care, speculated Chad Worz, Pharma, chief government officer of the American Society of Guide Pharmacists.
“That can change into extra obvious this week,” Worz advised McKnight’s.
He added he doesn’t see any entities “difficult the pause till extra is understood within the subsequent few days, however they might in accordance with the federal steering that it’s a provider-patient resolution based mostly on threat/profit.” For added protection, learn our sister website McKnight’s Senior Residing.